๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents

โœ Scribed by Rioux, N

Book ID
121762453
Publisher
Oxford University Press
Year
1998
Tongue
English
Weight
238 KB
Volume
19
Category
Article
ISSN
0143-3334

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phospholipase C Inhibitors: A New Class
Phospholipase C Inhibitors: A New Class of Agents
โœ Perrella, Frank W.; Chen, Shih-Fong; Behrens, Davette L.; Kaltenbach, Robert F. ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› American Chemical Society ๐ŸŒ English โš– 793 KB
Development of chemopreventive agents fo
Development of chemopreventive agents for bladder cancer
โœ Gary J. Kelloff; Charles W. Boone; Winfred F. Malone; Vernon E. Steele; Linda A. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 943 KB

The term cancerchemoprevention refers to the prevention or prolongation of carcinogenesis by intervention with drugs prior to the malignant (i.e., invasive) stage. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch of the National Cancer Institute. Neoplast

Colon cancer chemoprevention: Clinical d
Colon cancer chemoprevention: Clinical development of aspirin as a chemopreventive agent
โœ Krishnan, Koyamangalath; Ruffin, Mack T.; Brenner, Dean E. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB ๐Ÿ‘ 2 views

We have studied aspirin as a potential chemopreventive for colorectal cancer, completing Phase I studies on aspirin pharmacology and potential biomarker assays (prostaglandins, PGE 2 and PGF 2โฃ and cyclooxygenase modulation) in normal human subjects. These studies have determined the optimal dose of